Ignite Creation Date:
2025-12-24 @ 12:12 PM
Ignite Modification Date:
2025-12-29 @ 7:11 AM
Study NCT ID:
NCT02598661
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-26
First Post:
2015-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Sponsor:
Geron Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-10-13
Completion Date Type:
ESTIMATED
First Submit Date:
2015-10-27
First Submit QC Date:
None
Study First Post Date:
2015-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-09-24
Results First Submit QC Date:
None
Results First Post Date:
2025-02-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-05
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED